San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Mary Ann Barnes Leaving San Diego Post for New Role With Kaiser

Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is headed to the tropics to take on a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.

La Jolla Biotech Company Targets China for Arthritis Drug Trials

RuiYi Inc., a biotechnology company split between La Jolla and Shanghai, has received $15 million in Series B financing from existing investors to further its uncommon business model.

Tease photo

New Drug ‘Pipeline’ Runs Under the Sea

BIOTECH: Sirenas Exploring Oceans to Find Possible Cures

Sirenas Marine Discovery Inc. is in an enviable position — it’s actually turning away investors as it turns to the ocean’s depths as a promising source for potential new drugs.

Gary and Mary West Health Investment Fund Announces Sale of Sense4Baby Inc.'s Assets

The Gary and Mary West Health Investment Fund made a series of announcements – most notably that the assets of Sense4Baby Inc., its smartphone-based pregnancy monitoring company, have been acquired by San Antonio’s AirStrip Technologies LP.

RuiYi Receives $15M in Funding

RuiYi Inc., a biotech based both in La Jolla and Shanghai, has received $15 million in Series B financing from a group of existing investors.

Assay Depot Receives $3M in Series B Funding

Assay Depot Inc., Carlsbad’s self-dubbed “Amazon.com for scientists,” has landed $3 million in Series B funding.

SeniorQuote Insurance Services Completes $1.4M Funding Round

San Diego-based SeniorQuote Insurance Services Inc. has completed a $1.4 million Series A round.

Seragon Pharmaceuticals Names Former Onyx Pharmaceuticals CEO to its Board

Newly formed Seragon Pharmaceuticals Inc. has appointed N. Anthony Coles, the former CEO and board chairman of Onyx Pharmaceuticals Inc., to its board of directors.

Tease photo

Construction Complete on New UCSD Biomedical Research Facility

Construction is complete for the new, $113 million University of California, San Diego Health Sciences Biomedical Research Facility.

Construction Complete on UCSD Biomedical Research Facility

Construction is complete for the new, $113 million University of California, San Diego Health Sciences Biomedical Research Facility.

Coalition Seeks to Curb Problem of Drug Theft at Open Houses

A coalition of businesses, nonprofits and San Diego real estate professionals has banded together to prevent prescription drug theft at open houses. Key to the group’s mission is ensuring the safe use, storage and disposal of prescription drugs.

Anaptys Lands Lucrative Development Deal

BIOTECH: Tesaro Will Develop 3 of Co.’s Drugs

AnaptysBio Inc., a player in the hot field of cancer immunotherapy, has attracted $17 million up front in a drug development rights deal with Massachusetts-based Tesaro Inc. that could ultimately be worth hundreds of millions more.

New Life Sciences Co. Ready to Buy Others

BIOTECH: No Narrow Niches For Maravai and Local CEO

Chicago private equity firm GTCR is doling out up to $300 million to launch Maravai Life Sciences Inc. in San Diego, tapping the expertise of former Gen-Probe Inc. executives Carl Hull and Eric Tardif to lead a new, acquisition-driven venture.

Richard Branson to Be Keynote Speaker at Biotech Convention Set for San Diego

Billionaire Virgin Group founder Richard Branson will be the keynote speaker at the 2014 Bio International Convention in San Diego — one of the nation’s largest biotechnology forums that attracts more than 15,000 attendees each year.